Annual CFF
$21.23 M
+$18.47 M+667.92%
December 31, 2023
Summary
- As of February 8, 2025, EFTR annual cash flow from financing activities is $21.23 million, with the most recent change of +$18.47 million (+667.92%) on December 31, 2023.
- During the last 3 years, EFTR annual CFF has risen by +$23.13 million (+1222.25%).
- EFTR annual CFF is now -63.89% below its all-time high of $58.81 million, reached on December 31, 2021.
Performance
EFTR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$14.23 M
+$8.12 M+132.97%
March 31, 2024
Summary
- As of February 8, 2025, EFTR quarterly cash flow from financing activities is $14.23 million, with the most recent change of +$8.12 million (+132.97%) on March 31, 2024.
- Over the past year, EFTR quarterly CFF has increased by +$14.02 million (+6613.21%).
- EFTR quarterly CFF is now -73.13% below its all-time high of $52.96 million, reached on September 30, 2021.
Performance
EFTR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$35.25 M
+$14.02 M+66.03%
March 31, 2024
Summary
- As of February 8, 2025, EFTR TTM cash flow from financing activities is $35.25 million, with the most recent change of +$14.02 million (+66.03%) on March 31, 2024.
- Over the past year, EFTR TTM CFF has increased by +$35.01 million (+14347.95%).
- EFTR TTM CFF is now -40.08% below its all-time high of $58.83 million, reached on September 30, 2021.
Performance
EFTR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
EFTR Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +667.9% | +6613.2% | +10000.0% |
| 3 y3 years | +1222.3% | +6613.2% | +10000.0% |
| 5 y5 years | +1222.3% | +6613.2% | +10000.0% |
EFTR Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -63.9% | +667.9% | -2.3% | >+9999.0% | -40.1% | >+9999.0% |
| 5 y | 5-year | -63.9% | +1222.3% | -73.1% | >+9999.0% | -40.1% | >+9999.0% |
| alltime | all time | -63.9% | +1222.3% | -73.1% | >+9999.0% | -40.1% | >+9999.0% |
EFFECTOR Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | - | $14.23 M(+133.0%) | $35.25 M(+66.0%) |
| Dec 2023 | $21.23 M(+667.9%) | $6.11 M(+1686.3%) | $21.23 M(+40.7%) |
| Sep 2023 | - | $342.00 K(-97.7%) | $15.09 M(+1.6%) |
| Jun 2023 | - | $14.57 M(+6772.6%) | $14.86 M(+5988.5%) |
| Mar 2023 | - | $212.00 K(-673.0%) | $244.00 K(-91.2%) |
| Dec 2022 | $2.77 M | -$37.00 K(-133.3%) | $2.77 M(-0.5%) |
| Sep 2022 | - | $111.00 K(-364.3%) | $2.78 M(-95.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$42.00 K(-101.5%) | $55.63 M(+0.1%) |
| Mar 2022 | - | $2.73 M(<-9900.0%) | $55.59 M(-5.5%) |
| Dec 2021 | $58.81 M(-3208.3%) | -$22.00 K(-100.0%) | $58.81 M(-0.0%) |
| Sep 2021 | - | $52.96 M(<-9900.0%) | $58.83 M(+902.2%) |
| Jun 2021 | - | -$78.00 K(-101.3%) | $5.87 M(-1.3%) |
| Mar 2021 | - | $5.95 M | $5.95 M |
| Dec 2020 | -$1.89 M | - | - |
FAQ
- What is eFFECTOR Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics annual CFF year-on-year change?
- What is eFFECTOR Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics quarterly CFF year-on-year change?
- What is eFFECTOR Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for eFFECTOR Therapeutics?
- What is eFFECTOR Therapeutics TTM CFF year-on-year change?
What is eFFECTOR Therapeutics annual cash flow from financing activities?
The current annual CFF of EFTR is $21.23 M
What is the all time high annual CFF for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high annual cash flow from financing activities is $58.81 M
What is eFFECTOR Therapeutics annual CFF year-on-year change?
Over the past year, EFTR annual cash flow from financing activities has changed by +$18.47 M (+667.92%)
What is eFFECTOR Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of EFTR is $14.23 M
What is the all time high quarterly CFF for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high quarterly cash flow from financing activities is $52.96 M
What is eFFECTOR Therapeutics quarterly CFF year-on-year change?
Over the past year, EFTR quarterly cash flow from financing activities has changed by +$14.02 M (+6613.21%)
What is eFFECTOR Therapeutics TTM cash flow from financing activities?
The current TTM CFF of EFTR is $35.25 M
What is the all time high TTM CFF for eFFECTOR Therapeutics?
eFFECTOR Therapeutics all-time high TTM cash flow from financing activities is $58.83 M
What is eFFECTOR Therapeutics TTM CFF year-on-year change?
Over the past year, EFTR TTM cash flow from financing activities has changed by +$35.01 M (+14347.95%)